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We determined the prevalence and characteristics 
of extended-spectrum β-lactamase (ESBL) genes of 
Enterobacteriaceae in retail chicken meat and humans in 
the Netherlands. Raw meat samples were obtained, and 
simultaneous cross-sectional surveys of fecal carriage were 
performed in 4 hospitals in the same area. Human blood 
cultures from these hospitals that contained ESBL genes 
were included. A high prevalence of ESBL genes was found 
in chicken meat (79.8%). Genetic analysis showed that 
the predominant ESBL genes in chicken meat and human 
rectal swab specimens were identical. These genes were 
also frequently found in human blood culture isolates. 
Typing results of Escherichia coli strains showed a high 
degree of similarity with strains from meat and humans. 
These  ﬁ   ndings suggest that the abundant presence of 
ESBL genes in the food chain may have a profound effect 
on future treatment options for a wide range of infections 
caused by gram-negative bacteria.
I
nfections with drug-resistant bacteria are associated with 
higher rates of illnesses and deaths, which have a serious 
effect on costs of health care (1,2). During the past decade, 
drug resistance in Enterobacteriaceae has increased 
dramatically worldwide. This increase has been caused 
mainly by an increased prevalence of extended-spectrum 
β-lactamase (ESBL)–producing Enterobacteriaceae (3,4) 
and has increased the use of last-resort antimicrobial drugs 
(i.e., carbapenems).
ESBL genes are located on plasmids that can be 
easily transferred between and within bacterial species. 
Some ESBL genes are mutant derivatives of established 
plasmid-mediated  β-lactamases (e.g., blaTEM/SHV), and 
others are mobilized from environmental bacteria (e.g., 
blaCTX-M). During the 1990s, most reports on ESBL 
genes concerned blaTEM/SHV types, which were related to 
cross-infections in hospitals. However, the recent global 
increase has been caused mainly by blaCTX-M–type genes. 
The epidemiology of ESBL genes is changing rapidly 
and shows marked geographic differences in distribution 
of genotypes of blaCTX-M β-lactamases (5). In the United 
States, the most prevalent drug resistance gene in humans 
is currently blaCTX-M-15, which is often associated with a 
widely distributed variant of Escherichia coli O:25b, 
sequence type 131 (ST131). Bacteria containing ESBL 
genes are currently a common cause of infections 
originating in community-dwelling persons without a 
history of hospitalization, and these organisms can then 
be introduced into hospitals (6–9).
Fecal carriage of ESBL genes has been identiﬁ  ed as 
the major reservoir in the environment, but the original 
source of this colonization has not been clearly identiﬁ  ed. 
Because bacterial species that carry ESBL genes are 
normal inhabitants of the gastrointestinal tract, food is a 
potential source of them. The presence of ESBL genes 
has been clearly documented in food-production animals, 
especially chickens (10,11). Drug resistance in animals is 
caused mainly by the large amount of antimicrobial drugs 
used in food production. In addition to their presence in 
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farm animals, ESBL genes have been found in retail meat 
(12,13). A recent survey of broiler chickens in Great Britain 
found that blaCTX-M-1 was the most prevalent ESBL gene 
(14). Although ESBL genes in food-production animals 
pose a potential threat to humans, Randall et al. concluded 
that drug resistance genes in chickens (blaCTX-M-1) differed 
from the drug resistance genes most frequently found in 
humans (blaCTX-M-15) (14).
In the Netherlands, use of antimicrobial drugs and 
associated drug resistance in humans is among the lowest 
in Europe (15). Paradoxally, use of antimicrobial drugs 
in food-production animals in this country is among the 
highest in Europe (16). Therefore, the Netherlands provides 
a good setting to monitor spread of drug resistance from an 
animal reservoir into the human population. This spread was 
recently exempliﬁ  ed by emergence of livestock-associated 
methicillin-resistant Staphylococcus aureus in pigs and veal 
calves. This was ﬁ  rst reported in the Netherlands in 2004 
and has now been reported worldwide (17). The aim of our 
study was to determine the prevalence of ESBL genes in 
retail meat and hospitalized patients in the Netherlands and 
to compare ESBL genes and bacterial strains involved.
Methods
Meat Survey
During August 17–October 30, 2009, a prospective 
observational study was conducted in 4 hospitals in the 
southern part of the Netherlands (Sint Elisabeth Hospital 
in Tilburg, Twee Steden Hospital in Tilburg, Amphia 
Hospital in Breda, and Lievensberg Hospital in Bergen 
op Zoom). Randomly chosen packages of meat from 
major grocery stores in the region of the 4 participating 
hospitals were included. Each sample was derived from a 
different package containing raw and unspiced meat. All 
samples were incubated for 16–18 h at 37°C in 15 mL 
of tryptic soy broth (TSB). Subsequently, 100 μL of the 
initial broth sample was transferred into a second sample of 
TSB broth containing 8 mg/L vancomycin and 0.25 mg/L 
cefotaxime. After overnight incubation, 10 μL of the broth 
was placed on a chromogenic agar plate selective for ESBL 
(bioMérieux, Marcy l’Etoile, France), and the plates were 
incubated overnight. Colonies with distinct morphologic 
appearance were further characterized.
Species and resistance patterns of oxidase-negative, 
gram-negative rods were determined by using the Vitek2 
System (bioMérieux). Phenotypic conﬁ  rmation of ESBL 
was performed by using Etest (bioMérieux) for all 
isolates. A combination of ceftazidime, cefotaxime, and 
cefepime with and without clavulanic acid was used. If 
the MIC of >1 of the cephalosporins showed an 8-fold 
reduction in combination with clavulanic acid, the isolate 
was considered to be an ESBL producer. If the Etest 
result was inconclusive, a combination disk diffusion test 
(Rosco, Taastrup, Denmark) was performed. All tests 
were performed and interpreted according to the National 
Guideline for the Laboratory Detection of ESBL (18).
Fecal Carriage Survey
In the 4 hospitals in the same area were the meat had 
been obtained, 2 consecutive prevalence surveys were 
performed 3 weeks apart (November 1–December 20, 
2009) as part of each hospital’s infection control program. 
Patients who had positive results for ESBL at the ﬁ  rst 
sampling were excluded from subsequent sampling. These 
hospitals provide care to ≈1 million persons. Rectal swabs 
specimens were obtained from all patients admitted to 
the internal medicine, surgery, urology, pulmonology, 
and intensive care unit wards. Patients <18 years of age 
or those who had a colostomy were excluded. Rectal 
swab specimens were incubated in TSB broth cultures by 
using broth enrichment as described for the meat samples. 
Duration of hospitalization on the day of the survey was 
recorded for all participating patients.
Blood Cultures
All E. coli and Klebsiella spp. resistant to cefotaxime, 
including all strains presumably producing ESBL on the 
basis of microbiologic results, and isolated from clinical 
blood cultures, were obtained during July 2008–December 
2009 from the 4 study hospitals. Conﬁ  rmation of ESBL 
genes was performed as described for meat samples. Blood 
culture isolates were obtained from individual patients.
Genetic Characterization of Drug Resistance Genes
Characterization of drug resistance genes in all strains 
that were phenotypically ESBL producers was conducted 
2 ways. First, we tested all isolates for blaCTX-M by using 
denaturing high-performance liquid chromatography 
as described (19). Second, we screened for ESBL genes 
by using a micro-array (Check-Points, Wageningen, the 
Netherlands) that was designed to detect single nucleotide 
polymorphisms in essential blaTEM and blaSHV genes, variant 
genes, and blaCTX-M group genes (blaCTX-M-1,  blaCTX-M-2, 
blaCTX-M-9, and blaCTX-M-8/25). The procedure has been 
reported (20). Subsequently, sequencing was performed 
to further specify ESBL genotypes. On the basis of micro-
array results, blaSHV,  blaTEM, and blaCTX-M genes were 
ampliﬁ  ed by PCR and speciﬁ  c primers. PCR amplicons 
were selected and sequenced after puriﬁ  cation (Agencourt 
Ampure; Beckman Coulter, Leiden, the Netherlands). 
Sequence analysis and alignments were performed by 
using Bionumerics 6.01 software (Applied Maths, Sint-
Martens-Latem, Belgium), the BLAST program (http://
blast.ncbi.nlm.nih.gov/Blast.cgi), and information from 
the Lahey Clinic (Burlington, MA, USA) (www.lahey.org/
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studies). If results of denaturing high-perfomance liquid 
chromatography and DNA sequence were discordant, the 
DNA sequence was used as the correct result.
Multilocus Sequence Typing of E. coli Strains
All E. coli isolates from meat, rectal swab specimens, 
and blood cultures were typed by using multilocus sequence 
typing (MLST) as described by Wirth et al. (21). If patient 
or meat samples contained >1 morphologically distinct 
ESBL-producing E. coli strain, all strains were included in 
the MLST analysis.
Statistical Analysis
Data were analyzed by using SPSS version 18 software 
(SPSS, IBM, Somers, NY, USA). Univariate analysis was 
performed for calculation of difference in prevalences 
by using the χ2 test. One sample could contain >1 strain 
because morphologically distinct colonies with different 
drug resistance genes or a different MLST result were all 
included in the ﬁ  nal analysis.
Results
Meat Survey
A total of 262 fresh meat samples were included in 
this study (mean weight 11.9 g). The type of meat was 
chicken (n = 89, 34.0%), beef (n = 85, 32.4%), pork (n 
= 57, 21.8%), mixed or ground meat (n = 22, 8.4%), and 
other types of meat (n = 9, 3.4%). Phenotypic screening 
initially identiﬁ  ed 112 samples containing possible ESBL 
producers. Genotypic conﬁ  rmation identiﬁ  ed 79 (30.2%) 
ESBL-producing samples. Some samples contained >1 
type of ESBL gene. Prevalence of ESBL genes differed 
among the 4 meat groups: 71 (79.8%) in chicken, 4 (4.7%) 
in beef, 1 (1.8%) in pork, 2 (9.1%) in mixed or ground 
meat, and 1 (11.1%) in other types of meat. ESBL gene 
prevalence was signiﬁ  cantly higher in chicken (p<0.001 for 
all comparisons with other meat types).
Fecal Carriage Survey
A total of 927 rectal swab specimens were obtained 
from 876 patients (461 male patients and 415 female 
patients, mean ± SD age 65.7 ± 16.8 years). Phenotypic 
screening identiﬁ  ed 59 patients as possibly being infected 
with ESBL-producing E. coli. Conﬁ  rmatory test results for 
ESBL genes were inconclusive for 2 samples and excluded 
(no inconclusive results were obtained with meat or blood 
cultures). A total of 45 (4.9%) samples contained conﬁ  rmed 
ESBL genes.
Blood Cultures
Thirty-one clinical blood cultures suspected of 
containing ESBL genes on the basis of phenotypic screening 
were available for further analysis. Genetic characterization 
conﬁ  rmed that 23 (74.2%) samples contained ESBL genes.
ESBL-producing Bacterial Species
Sixty-eight (76.8%) chicken meat samples contained 
ESBL-producing  E. coli, 6 (7.7%) contained ESBL-
producing Klebsiella spp., and 4 (5.1%) contained other 
ESBL-producing species. Of the 8 types found in other 
meat, all were ESBL-producing E. coli. Rectal swab 
specimens of hospitalized patients showed that 39 (69.6%) 
patients had E. coli, 11 (19.6%) had Klebsiella spp., and 8 
(10.7%) had other bacterial species. Blood cultures showed 
that 16 (64.0%) patients had E. coli and 9 (36.0%) had 
Klebsiella spp.
Drug Resistance Genes
The distribution of drug resistance genes from various 
sources is shown in Figure 1. The predominant ESBL 
genotype in chicken meat was blaCTX-M-1 (n = 50, 58.1%). 
This genotype was also the most frequent ESBL genotype 
in rectal swab specimens (n = 22, 45.8%) and the second 
most common in blood cultures (n = 5, 20.8%). In chicken 
meat, blaCTX-M-1 (n = 50, 58.1%) was the most common 
genotype, followed by blaTEM-52 (n = 12, 14.0%) and blaSHV-12 
(n = 12, 14.0%). In other types of meat, 5 (62.5%) of 8 
ESBL genotypes were blaCTX-M-1. In rectal swab specimens 
of hospitalized patients, blaCTX-M-1 (n = 22, 45.8%) was 
the most common genotype, followed by blaCTX-M-15 (n = 
8, 16.7%) and blaTEM-52 (n = 6, 12.5%). In blood cultures, 
blaCTX-M-14 was the predominant genotype (n = 8, 33.3%).
Epidemiology of Patients and Drug Resistance Genes
When we compared the most prevalent drug resistance 
genes in 346 patients who had been hospitalized <48 h 
at the time of screening with 581 patients who had been 
hospitalized >48 h, prevalence was similar for blaCTX-M-1 
(2.3% and 2.4%, respectively) and for TEM-52 (0.6% 
and 0.7%, respectively) in the 2 groups. Prevalence of 
blaCTX-M-15 was 4× higher in the group that was hospitalized 
longer (0.3% and 1.2%, respectively; p = 0.27). There was 
only 1 possible cluster of cases (same resistance gene at 
the same time at the same ward), which involved 3 patients 
with blaCTX-M-15. One patient was infected with E. coli and 2 
were infected with K. pneumoniae.
MLST of E. coli
MLST results of 158 ESBL-positive E. coli strains 
isolated from chicken meat, other meat types, rectal swab 
specimens, and blood cultures are shown in Figure 2. E. 
coli containing ESBL genes showed a heterogeneous 
population that contained several clusters. Most clusters 
contained strains isolated from meat and humans. All but 
1 of the ESBL-producing strains from other meat types 
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clustered with strains from chicken meat. Twenty-ﬁ  ve 
(56.8%) of 44 strains from rectal swab specimens and 9 
(56.3%) of 16 strains from blood cultures clustered with 
strains from chicken meat.
MLST results for strains with blaCTX-M-1, blaCTX-M-15, and 
blaTEM-52 are shown in Figure 2. Genotypes blaCTX-M-1 and 
blaTEM-52 showed a heterogeneous population and clusters 
containing strains from humans and meat. E. coli harboring 
blaCTX-M-15 was found less frequently, and no clusters with 
human-derived and meat-derived strains were observed. 
The widely disseminated ST131 clone was found in human 
samples only: 4 times in combination with blaCTX-M-15, twice 
with blaCTX-M-14, and once with blaSHV-12.
Discussion
ESBL genes were found in a high (79.8%) proportion 
of retail chicken meat samples in the Netherlands. A 
comparison of ESBL-producing Enterobacteriaceae 
derived from meat and hospitalized patients showed a 
high degree of similarity of resistance genes and MLST 
patterns. Genotype blaCTX-M-1 was the most frequent drug 
resistance gene in chicken meat and humans and the 
second most frequent in blood cultures. Other meat types 
contained similar drug resistance genes, but the prevalence 
of ESBL genes was much lower. It is unclear whether 
ESBL genes in other meat types are related to a reservoir 
in food-production animals or contamination at meat-
processing facilities. An extensive reservoir of ESBL genes 
on farms was repeatedly shown in poultry (10,11). Our 
ﬁ  ndings suggest a relationship between contamination of 
chicken meat with drug-resistant bacteria and appearance 
of ESBL genes in humans in the Netherlands. This 
relationship was further supported by genomic comparison 
of strains detected in chicken meat with those detected 
in human fecal specimens. MLST showed that most E. 
coli strains harboring blaCTX-M-1 or blaTEM-52 from humans 
and meat belong to clusters containing strains from both 
sources. These ﬁ   ndings suggest a relationship between 
contamination of chicken meat and appearance of ESBL 
genes in humans in the Netherlands.
The high prevalence of ESBL genes in chicken meat 
is consistent with ﬁ  ndings of other investigators. Doi et al. 
reported that 67% of retail meat samples in Seville, Spain, 
contained ESBL or ESBL-like resistance genes (12). A 
survey of imported raw chicken in the United Kingdom 
reported ESBL genes in 10 of 27 samples (13). The authors 
concluded that ESBL genes in meat pose a potential threat 
to humans, but that the most prevalent ESBL genotype in 
humans in the United Kingdom (blaCTX-M-15) was not found 
in imported meat.
In our study, we found a high degree of similarity 
between drug resistance genes in humans and retail 
meat. A possible explanation for this ﬁ  nding is that in the 
Netherlands, where drug resistance in bacterial isolates 
in humans is less frequent (15) and cross-transmission in 
hospitals is controlled effectively (22), the role of acquiring 
drug-resistant strains from food is more easily detected. 
In addition, the Netherlands is one of the highest users of 
antimicrobial agents in food-production animals (16), which 
results in high rates of drug resistance among these animals. 
A report by the Veterinary Antibiotic Usage and Resistance 
Surveillance Working Group showed that cefotaxime-
resistant E. coli in poultry meat in the Netherlands has 
emerged since 2005 (23). This ﬁ  nding coincides with the 
increase in third-generation cephalosporin-resistance in E. 
coli and K. pneumonia bacteria in invasive infections in 
humans reported by the European Antimicrobial Resistance 
Surveillance Network (24).
We performed a prevalence survey among hospitalized 
patients to determine the size and nature of the reservoir 
of ESBL genes. Nearly 5% of all hospitalized patients 
were carriers of ESBL genes. It is difﬁ   cult to put this 
rate into context because no screening studies have been 
conducted in the Netherlands. A large study in Chicago, 
Illinois, USA, found that during 2000–2005, the rate of 
ESBL gene carriage among high-risk, hospitalized patients 
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Figure 1. Distribution of extended-spectrum β-lactamase genes in chicken meat (A), human rectal swabs (B), and human blood cultures 
(C), the Netherlands. Values in pa    rentheses are no. positive.RESEARCH
increased from 1.3% to 3.2%, and bacteremia developed 
in 8.5% of all previously identiﬁ  ed ESBL gene carriers 
during hospitalization (25). In Spain, an increase was also 
observed in fecal carriage in hospitalized patients from 
0.3% in 1991 to 11.8% in 2003 (7).
The rate we observed in 2009 in the Netherlands 
was lower than rates in Spain in 2003, which would be 
expected because of low antimicrobial drug resistance rates 
in the Netherlands (24). Conversely, a prevalence of 5% 
extrapolated to the Dutch population in 2011 (16,700,000 
inhabitants) would indicate that currently >800,000 persons 
in the Netherlands are colonized with ESBL-producing 
bacteria. Because use of antimicrobial drugs in the health 
care setting in the Netherlands is low and has not changed 
during the past decade, alternative factors for increased 
drug resistance are not known. An indication for the role of 
a community reservoir is the prevalence of drug resistance 
genes in patients who had been hospitalized <48 h and 
those hospitalized >48 h. Drug resistance genes that are 
associated with a proposed food reservoir (26) (blaCTX-M-1 
and  blaTEM-52) were already present at hospitalization. 
However, blaCTX-M-15, which is reported to be associated 
with health care settings (26), had a higher, albeit not 
signiﬁ  cant, prevalence in the group who had been in the 
hospital >48 h.
Considering what is known about the epidemiology 
of E. coli, the abundance of ESBL genes in chicken meat 
is a likely explanation for current ﬁ   ndings in humans. 
Although there are extensive campaigns promoting safe 
handling of chicken meat during processing, enteric 
pathogens are frequently transferred to humans and pose a 
continuous public health threat (27). Johnson et al. studied 
geographically and temporally matched E. coli isolates 
from humans and poultry (28). Drug-susceptible E. coli 
isolates from humans differed from drug-resistant isolates 
from humans and from isolates in poultry irrespective of 
their drug resistance pattern. Drug-susceptible isolates 
from poultry were similar to drug-resistant isolates of 
poultry and humans. Their conclusion was that drug-
resistant human fecal E. coli isolates likely originate from 
poultry, whereas drug-resistant E. coli isolates from poultry 
likely originate from susceptible precursors in poultry. In 
vitro experimental support for our hypothesis comes from 
a recent study showing transfer of a blaTEM-52–carrying 
plasmid from an avian E. coli strain to 2 human E. coli 
strains in a continuous ﬂ  ow culture model (29).
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Figure 2. Multilocus sequence typing patterns of Escherichia coli from chicken meat, other meat types, human rectal swabs, and human 
blood cultures, the Netherlands. A) All E. coli containing extended-spectrum β-lactamase genes; B) E. coli containing blaTEM-52; C) E. coli 
containing blaCTX-M-1; D) E. coli containing blaCTX-M-15. Major sequence types are shown as numbers. Black connecting lines indicate single-
locus variants; gray connecting lines indicate double-locus variants; dashed connecting lines indicate strains with >3 loci that are different; 
and shadowing indicates that >2 sequence types belong to 1 complex.ESBL Genes of E. coli in Chicken Meat and Humans
Emergence of ESBL genes in poultry has been 
associated with use of third-generation cephalosporins 
(particularly ceftiofur) in chickens. In Canada, a strong 
correlation was found between incidence of ceftiofur-
resistant Samonella enterica serovar Heidelberg in humans 
and retail chickens (30). Use of ceftiofur in animals 
was stopped voluntarily, and ceftiofur resistance rates 
subsequently decreased in retail chicken meat and humans. 
After partial reintroduction of this drug, resistance rates in 
poultry and humans increased, providing further evidence 
for a zoonotic source of ESBL genes.
Overrepresentation of ST131 in blood cultures 
conﬁ  rms the virulent properties attributed to this clone. 
Typically, ST131 is found in association with blaCTX-M-15. 
In our survey, ST131 strains were associated with 3 drug 
resistance genes. This ﬁ  nding indicates that this virulent 
clone also acquires other drug resistance genes. We did 
not  ﬁ   nd ST131 in the chicken meat samples, which is 
reassuring at this time. However, other studies have recently 
identiﬁ  ed ST131 in poultry and retail meat (31,32). These 
ﬁ  ndings conﬁ  rm that virulent clones of E. coli are capable 
of crossing species barriers between humans and animals. 
In addition, mobile drug resistance genes also cross this 
barrier and are likely to accelerate dissemination of drug 
resistance between animals and humans.
We conclude that the high rate of ESBL contamination 
of retail chicken meat in the Netherlands, which involves 
many of the same ESBL genes present in colonized and 
infected humans, is a plausible source of the recent increase 
of ESBL genes in the Netherlands. The similarity of E. coli 
strains and predominant drug resistance genes in meat and 
humans provides circumstantial evidence for an animal 
reservoir for a substantial part of ESBL genes found in 
humans. The threat of the high rate of antimicrobial drug use 
in food-production animals and associated emergence of 
drug resistance in zoonotic pathogens has been recognized 
for decades. Our group and others found that most samples 
of retail chicken meat contain transmissible drug resistance 
genes in bacterial species that are part of the normal human 
intestinal ﬂ  ora. This ﬁ  nding may have a profound effect on 
future treatment options for a wide range of infections with 
gram-negative bacteria.
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